enGene Holdings Inc.
NASDAQ:ENGNBiotechnology
-$0.02 today
- Market cap
- $115.27M
- Beta
- -0.29
- P/E (TTM)
- -1.8
- EPS (TTM)
- -$0.95
Volume 1.64M
Average 1.58M
Returns on capital
enGene Holdings Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-69.9%
avg -44.3%
ROIC
-61.7%
avg -23.5%
ROA
-53.0%
avg -37.0%
Analysis
ROA is currently the strongest return metric at -53.0% versus its period average of -37.0%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Ronald H. W. Cooper | President, Chief Executive Officer & Director | USD 1.21M | 63 | — | — |
Anthony T. Cheung | Consultant | USD 341.75K | 54 | — | — |
William J. Grossman | Interim Chief Medical Officer & Director | USD 15.99K | 56 | — | — |
Matthew Boyd | Chief Regulatory Officer | — | 52 | — | — |
Amy Pott | Chief Global Commercialization Officer | — | 50 | 400.00K | 0.78% |
Jill Buck | Chief Development Officer | — | 52 | 195.00K | 0.38% |
Joan Connolly | Chief Technology Officer | — | 56 | 195.00K | 0.38% |
Kathleen Richton | Senior VP of Finance, Principal Accounting & Financial Officer and Controller | — | 48 | — | — |
Tara Place | Senior Vice President of Human Resources | — | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Jan 30, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
1
$10,050.94
Sells
0
$0.00
Net Transaction Value
+$10,050.94
Net buying
Most Active
Grossman William
1 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Sep 22, 26Sep 22, 2026 | Grossman William Direct | Buy | $10.1K$10,050.94 |
Summary
Insiders reported 1 buys worth $10,050.94 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $10,050.94. Grossman William was the most active insider with 1 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A2 analysts |
| Revenue | N/A | N/A | N/A | N/A2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | N/A | N/A2 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Who does enGene Holdings Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Questions
Management questions
Common questions about ENGN's management, answered from reported figures.
Who manages ENGN?
enGene Holdings Inc. (ENGN) lists 9 active executives. The top listed executive is Anthony T. Cheung, Consultant.
Are ENGN insiders buying or selling?
Recent insider activity shows net buying of $109.93M.
Continue the stock analysis
Jump to another research area for this company.